Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $1,183 - $2,100
-10 Reduced 0.41%
2,406 $432,000
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $9,563 - $15,728
81 Added 3.47%
2,416 $286,000
Q2 2022

Aug 11, 2022

SELL
$117.13 - $176.59 $2,811 - $4,238
-24 Reduced 1.02%
2,335 $334,000
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $188,678 - $350,694
1,492 Added 172.09%
2,359 $406,000
Q4 2021

Feb 09, 2022

BUY
$225.82 - $368.51 $4,064 - $6,633
18 Added 2.12%
867 $220,000
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $188,393 - $411,315
849 New
849 $327,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.